Table 2 Vitamin D metabolite level at baseline and day 3 after enrollment
Vitamin D metabolite | Survivors at 28 days Mean (CI 95%) | Non-survivors at 28 days Mean (CI 95%) | p value |
|---|---|---|---|
Vitamin D supplementation group, day 0 | |||
 25-Hydroxyvitamin D, ng/ml | 12.9 (12.2–13.6) | 13.0 (11.3–14.7) | 0.869 |
 1,25-Dihydroxyvitamin D, pg/ml | 44.3 (37.1–51.4) | 38.3 (21.9–54.7) | 0.527 |
Placebo group, day 0 | |||
 25-Hydroxyvitamin D, ng/ml | 13.6 (12.9–14.4) | 12.9 (11.6–14.4) | 0.382 |
 1,25-Dihydroxyvitamin D, pg/ml | 42.9 (36.3–49.4) | 34.6 (25.9–43.3) | 0.133 |
Vitamin D supplementation group, day 3 | |||
 25-Hydroxyvitamin D, ng/ml | 34.4 (31.7–37.2) | 25.4 (20.2–30.6) | 0.010 |
 1,25-Dihydroxyvitamin D, pg/ml | 107.6 (92.7–122.6) | 70.3 (36.0–104.7) | 0.056 |
Placebo group, day 3 | |||
 25-Hydroxyvitamin D, ng/ml | 13.9 (13.2–14.7) | 13.9 (12.1–15.7) | 0.948 |
 1,25-Dihydroxyvitamin D, pg/ml | 50.7 (42.2–59.2) | 37.4 (26.5–48.4) | 0.059 |